Skip to main content
Image
The future of neuromuscular monitoring

How TetraGraph redefines quantitative train-of-four (TOF) monitoring

Invented by an anesthesiologist wanting to do better for his patients, Senzime's TetraGraph is backed by clinical research at leading hospitals.

TetraGraph is the most rigorously studied quantitative TOF monitor available, widely used in clinical practice today.

TetraGraph has not only streamlined our anesthesia workflow, but has also elevated the standard of care we provide to our patients.

- Steve Hultgren, Anesthesia Technician Supervisor at CHI Health

Image
Latest @ Senzime Linkedin
 
Our expertise – Your confidence

40

years of research as backbone of products

107

approved patents, and counting

45

clinical studies

4150

shipments of TetraGraph systems, and counting
Enhancing your daily practice

Supporting you from start to finish

We provide more than cutting-edge technology. Our commitment extends to helping you excel with resources and support tailored to your needs.

Learn about the latest clinical guidelines, get started with quantitative TOF monitoring, and access valuable insights to improve patient outcomes.

Senaste bloggar
| Blog
From tradition to evidence: The case for ADM in neuromuscular monitoring
| Blog
TetraGraph Level-of-Block Gauge: Visual Clarity in Real-Time
| Blog
Why Quantitative Train-of-Four (TOF) Monitoring Is Essential for Modern Anesthesia Practice
| Blog
Quantitative neuromuscular monitoring: a crucial contributor to enhanced postoperative recovery
Senzime is leading the new standard of care

Senzime is a leading medical device company at the forefront of a changing healthcare market, driven by new clinical guidelines and emerging technologies.